|
Dr. Edward J. Benz, Jr., MD, former president and CEO of Dana-Farber Cancer Institute talks about Dana Farber’s role in healthcare innovation and how this large institute interfaces with the…
|
|
A fireside chat on the financialization of the pharmaceutical industry and its effects on drugs by Economist Dr. William Lazonick. The event is organized by the Center for Integration of Science and…
|
|
Featuring Andy Aylesworth (Marketing), Miriam Boeri (Sociology), Liz Brown (Law, Tax and Financial Planning), Jeff Moriarty (Philosophy) and Zoe Wagner (Natural and Applied Sciences)
We’ll be…
|
|
Remedies (Chairs: David Yates, Joseph Weiss, Patricia Flynn)
Ben Aslinger; Miriam Boeri; Jane De Leon Griffin; Gesa Kirsch; Fred Ledley, Ekaterina Cleary & Sarah McCoy; Stephanie Medden; Jeffrey…
|
|
A fireside chat with Dr. Gary J. Nabel, M.D., Ph.D.
Dr. Gary J. Nabel, M.D., Ph.D., is Chief Scientific Officer, Global Research and Development, and Head of the North American R&D Hub at…
|
|
Valente Center 2019 Distinguished Visiting Scholar Dr. Jay Labov
Fireside Chat with Dr. Xue Simon
|
|
Ekaterina Cleary, Bentley research associate and lead author of the study; Deborah Dunsire, CEO of Xtuit Pharmaceuticals; Chris Garabedian, CEO of Xontogeny; Mark Namchuk, senior vice president of…
|
|
Bentley alumnus Lance Colwell, and MIldon Farrwell, from Biogen, discuss the commercial launch of a revolutionary new product, Spiranza
|
|
2nd Raytheon Lectureship in Business Ethics;
Raymond Gilmartin, President and CEO of Merck & Co. Inc.
|
|
9th Sears Lectureship in Business Ethics;
Ralph Larsen, Chairman and CEO of Johnson & Johnson.
|